Search clinical trials for: Disease Modifying Therapy (DMT)

Total 390566 results

Hebei Province Veterans Hospital

Completed

Dance/Movement Therapy for Bone Mineral Density in Schizophrenia

Schizophrenia

China
Rennes University Hospital

Recruiting

Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP) (STOP-I-SEP)

Multiple Sclerosis

France
University of Turin, Italy

Completed

Effectiveness of Aligners Versus Rapid Maxillary Expansion

Maxillary Transverse Deficiency (MTD)

Italy
Insel Gruppe AG, University Hospital Bern
Psychiatric University Hospital, Zurich

Recruiting

Molecular Imaging Study of Harmine/DMT: a Basic Research Approach (HaD-PET)

Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine

Switzerland
Universidade Federal do Rio Grande do Norte

Completed

Safety and Tolerability of DMT in Healthy Adults

Healthy Volunteers | Safety Issues

Brazil
Biomind Labs Inc.
Universidade Federal do Rio Grande do Norte

Completed

Clinical Study of DMT in Healthy Adults

Healthy Volunteers

Brazil
The University of Hong Kong
Tung Wah Group of Hospitals

Completed

Programme Evaluation on Effectiveness of The Use of Movement-based x 'Elderspirituality - Fu Le Mun Sum' Intervention to Support Elderly People With Depressive Symptoms

Depression in Old Age

Hong Kong
University Hospital, Basel, Switzerland

Completed

Acute Dose-dependent Effects of DMT in Healthy Subjects (DMT DR)

Healthy

Switzerland
Amasya University

Completed

Dance and Movement Therapy in Patients With Schizophrenia (DMTinSchizo)

Schizophrenia | Disabilities Mental | Negative Symptoms in Schizophrenia | Dance Therapy

Turkey
Centre de Recherche de l'Institut Universitaire...

Completed

Dancing for Better Aging: Evaluating the Impact of a Dance/Movement Therapy (D/MT) Program for Older Adults

Aging

Canada
University Health Network, Toronto
The Physicians' Services Incorporated Foundation

Completed

The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause

Osteoporosis | Osteopenia | Bone Density | Post-Menopause

Canada
Novartis Pharmaceuticals

Recruiting

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation (SOSTOS)

Relapsing-Remitting Multiple Sclerosis

Canada, United States
University Hospital, Basel, Switzerland

Not yet recruiting

Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study) (DMT BDR)

Healthy

Switzerland
Biogen

Terminated

Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (AFFINITY)

Multiple Sclerosis

United States, Italy, Spain, Belgium, Germany, Switzerland, Australia, Hungary, France, Poland, United Kingdom, Czechia, Israel, Canada, Netherlands
University of Utah
National Institutes of Health (NIH)

Completed

Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study (DMT)

Premature Birth of Newborn

United States
University of Colorado, Denver
EMD Serono; National Multiple Sclerosis Society

Completed

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

Multiple Sclerosis

United States
Delphinus Medical Technologies, Inc.
University of Chicago; Boston Biomedical Associates

Completed

Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3) (DMT SV RRS3)

Breast Cancer Detection | Dense Breast Parenchyma | Benign Breast Findings | Normal Breast Screening | Abnormal Breast Screening

United States
Novartis Pharmaceuticals

Completed

The 'Wearing Off' Effect of DMT

Multiple Sclerosis

Switzerland
Drexel University
Stony Brook University; National Center for Complementary and Integrative Health...

Unknown

Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain

Chronic Low-back Pain

United States
Max Nieuwdorp

Not yet recruiting

Effect of eHealth on AB Use of Children With Acute, Uncomplicated URTIs

Upper Respiratory Tract Infection

Netherlands
Monash University

Enrolling by invitation

Relationship Between Oral DMT Burden and Adherence in MS (STATURE)

Multiple Sclerosis | Adherence, Medication

Australia
Novartis Pharmaceuticals

Completed

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC) (EPOC)

Relapsing Remitting Multiple Sclerosis

Russian Federation
Yale University

Active, not recruiting

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Depression | Major Depressive Disorder

United States
Small Pharma Ltd

Completed

IM and IV SPL026 Drug Product in Healthy Participants

Major Depressive Disorder

United Kingdom
Tanta University

Unknown

Benefits of Nigella Sativa in Children With Beta Thalassemia Major (Nigella)

Nigella Sativa With Beta Thalassemia Major

Egypt
Delphinus Medical Technologies, Inc.
University of Chicago; Boston Biomedical Associates; Reed Technical Associates...

Completed

Delphinus SoftVue™ ROC Reader Study (DMT SV RRS2)

Breast Cancer Detection | Dense Breast Parenchyma | Benign Breast Findings | Normal Breast Screening | Abnormal Breast Screening

United States
Delphinus Medical Technologies, Inc.
University of Chicago; Reed Technical Associates, LLC; Biostatistics Consulting...

Completed

Delphinus SoftVue™ ROC Reader Study (DMT SV RRS1)

Breast Cancer | Breast Neoplasms

United States
University Hospital, Basel, Switzerland

Completed

Effects of Dimethyltryptamine in Healthy Subjects (DMT)

Healthy

Switzerland
Beckley Psytech Limited

Completed

Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects

Pharmacokinetics in Healthy Adults

United Kingdom
Bristol-Myers Squibb

Active, not recruiting

A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants

Multiple Sclerosis

United States
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients

Relapsing Multiple Sclerosis

United Kingdom
Psychiatric University Hospital, Zurich
University of Basel

Completed

Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects

Emotions | Mood | Cognitive Function 1, Social | Empathy

Switzerland
GH Research Ireland Limited

Completed

Clinical Study of GH001 in Depression

Depression | Major Depressive Disorder | Treatment Resistant Depression

Netherlands
Exsar Corporation

Suspended

Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease

Type I Gaucher Disease

United States
GH Research Ireland Limited

Completed

Safety of GH001 in Healthy Volunteers

Healthy Volunteers

Netherlands
TG Therapeutics, Inc.

Recruiting

Study to Evaluate Efficacy When Transitioning From a Current Disease Modifying Therapy (DMT) to Ublituximab (ENHANCE)

Relapsing Multiple Sclerosis

United States
Novartis Pharmaceuticals

Completed

Risk Perception in Multiple Sclerosis

Multiple Sclerosis

United States
Algernon Pharmaceuticals
Centre for Human Drug Research, Netherlands

Active, not recruiting

Single and Repeat Doses of DMT in Healthy Subjects

Stroke

Netherlands
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...

Recruiting

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) (BEAT-MS)

Relapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United States
University of Jyvaskyla
The Social Insurance Institution of Finland; Finnish Dance Therapy Association

Completed

Dance Movement Therapy in the Treatment of Depressed Patients: A Randomised Controlled Trial

Depression
GH Research Ireland Limited

Recruiting

Phase 2 Clinical Trial of GH001 in Postpartum Depression

Postpartum Depression | Postnatal Depression

United Kingdom, Netherlands
University Hospital, Caen
Genzyme, a Sanofi Company; Ligue contre le cancer, France

Completed

Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) Administration (PREMISEP)

C10.114.375.500

France
Small Pharma Ltd

Completed

SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients

Major Depressive Disorder

United Kingdom
GH Research Ireland Limited

Recruiting

Phase 2 Clinical Trial of GH001 in Bipolar II Disorder

Bipolar II Disorder

Netherlands, Germany
Universidade Federal do Rio Grande do Norte

Completed

Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression

Depressive Disorder | Depression, Unipolar

Brazil
Shalvata Mental Health Center

Unknown

Unified Cognitive-Behavioral Therapy (CBT) vs. Combined CBT and Dance/Movement Therapy (DMT) for Anxiety Disorders

Anxiety Disorders

Israel
University Hospital, Basel, Switzerland

Not yet recruiting

Acute Analgesic Effects of DMT on Experimentally Induced Pain in Healthy Participants (DPS)

Healthy

Switzerland
GH Research Ireland Limited

Completed

Pharmacokinetics of GH001 in Healthy Volunteers

Healthy Volunteers

Netherlands
Teikoku Pharma USA, Inc.

Not yet recruiting

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

Agitation
Small Pharma Ltd

Completed

SPL026 With or Without SSRIs in Participants With MDD

Major Depressive Disorder

United Kingdom

Search clinical trials for: Disease Modifying Therapy (DMT)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations